The pharmaceutical industry continues to expand its influence on global health, from controlling diseases to providing treatment options to better manage complex health conditions. It is now becoming increasingly obvious that overall global health can be improved not just by developing drugs and vaccines to manage health but also by ensuring that when treatment options are available, the information is relayed to the prescribers and patients in an unbiased manner so that there is increased adoption.
Key Opinion Leaders (KOLs), who are thought leaders and highly respected for their expertise in specific therapeutic areas, play a key role across the drug lifecycle ranging from drug discovery to analyzing treatment outcomes, to driving R&D efforts and helping with adoption.